Skip to content

Science Pulse

at Proud ScientistECG · AP · GW

Forum · Medicine · Story discussion

Nicotinamide Riboside for Patients With Early-Stage Parkinson Disease

This randomized trial assesses the effect of oral nicotinamide riboside treatment for 52 weeks vs placebo on clinical outcomes among patients with early Parkinson disease.

3 days ago — JAMA · Read the original

Peer reviews (0)

Comments (0)

No comments yet. Start the discussion.

Loading sign-in…